Lori Maxwell

630 total citations
13 papers, 478 citations indexed

About

Lori Maxwell is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Lori Maxwell has authored 13 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Physiology. Recurrent topics in Lori Maxwell's work include Cancer, Hypoxia, and Metabolism (3 papers), Virus-based gene therapy research (2 papers) and Cancer Research and Treatments (2 papers). Lori Maxwell is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Virus-based gene therapy research (2 papers) and Cancer Research and Treatments (2 papers). Lori Maxwell collaborates with scholars based in Canada, United States and Sweden. Lori Maxwell's co-authors include Charles H. Graham, Lisa J. Frederiksen, Michael Adams, D. Robert Siemens, Michael A. Adams, Jeremy P.W. Heaton, Shannyn K. Macdonald-Goodfellow, Brian M. Bennett, Richard Sullivan and B E Elliott and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Lori Maxwell

12 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lori Maxwell Canada	9	163	147	124	97	81	13	478
Jonghwa Jin South Korea	14	395 2.4×	210 1.4×	104 0.8×	67 0.7×	50 0.6×	31	716
Céline Tellier Belgium	6	202 1.2×	184 1.3×	89 0.7×	73 0.8×	28 0.3×	6	441
María A. Jasnis Argentina	15	238 1.5×	102 0.7×	184 1.5×	40 0.4×	48 0.6×	26	519
Bahar Salimian Rizi United States	5	185 1.1×	129 0.9×	75 0.6×	33 0.3×	57 0.7×	6	486
Jan Scicinski United States	16	425 2.6×	120 0.8×	318 2.6×	86 0.9×	123 1.5×	48	896
Michael M. Lizardo United States	14	349 2.1×	222 1.5×	247 2.0×	51 0.5×	68 0.8×	24	746
Lilia Ileva United States	13	377 2.3×	147 1.0×	117 0.9×	73 0.8×	50 0.6×	16	794
Mridula Swayampakula Canada	9	511 3.1×	113 0.8×	134 1.1×	41 0.4×	69 0.9×	12	648
Robert L. Howell United States	12	222 1.4×	106 0.7×	96 0.8×	44 0.5×	25 0.3×	14	424
Sara Pignatta Italy	15	332 2.0×	98 0.7×	313 2.5×	211 2.2×	31 0.4×	26	816

Countries citing papers authored by Lori Maxwell

Since Specialization

Citations

This map shows the geographic impact of Lori Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Maxwell more than expected).

Fields of papers citing papers by Lori Maxwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Maxwell. The network helps show where Lori Maxwell may publish in the future.

Co-authorship network of co-authors of Lori Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Maxwell. A scholar is included among the top collaborators of Lori Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Maxwell. Lori Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Maxwell, Lori, et al.. (2020). PARP inhibition suppresses the emergence of temozolomide resistance in a model system. Journal of Neuro-Oncology. 148(3). 463–472. 9 indexed citations

Maxwell, Lori, et al.. (2016). The Goldilocks Dilemma: A Case Study toward a "Just Right" Model of Service-Learning. International Journal of Learning Teaching and Educational Research. 15(12). 1 indexed citations

Maxwell, Lori, et al.. (2015). ATPS-50REVISITING CARBOPLATIN AS A THERAPY FOR GLIOBLASTOMA (GBM). Neuro-Oncology. 17(suppl 5). v29.2–v29. 1 indexed citations

Zemp, Franz J., Brienne McKenzie, Xueqing Lun, et al.. (2013). Resistance to Oncolytic Myxoma Virus Therapy in Nf1−/−/Trp53−/− Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon. PLoS ONE. 8(6). e65801–e65801. 15 indexed citations

McKenzie, Brienne, Hongyuan Zhou, Lori Maxwell, et al.. (2013). Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin. Neuro-Oncology. 15(7). 904–920. 40 indexed citations

Tremblay, Alain, David R. Stather, Paul MacEachern, et al.. (2008). USE OF A DRUG ELUTING PLEURAL CATHETER FOR PLEURODESIS. CHEST Journal. 134(4). 66S–66S. 2 indexed citations

Kelly, Margaret M., Kelly M. McNagny, David L. Williams, et al.. (2007). The Lung Responds to Zymosan in a Unique Manner Independent of Toll-Like Receptors, Complement, and Dectin-1. American Journal of Respiratory Cell and Molecular Biology. 38(2). 227–238. 22 indexed citations

Frederiksen, Lisa J., Richard Sullivan, Lori Maxwell, et al.. (2007). Chemosensitization of Cancer In vitro and In vivo by Nitric Oxide Signaling. Clinical Cancer Research. 13(7). 2199–2206. 109 indexed citations

Frederiksen, Lisa J., D. Robert Siemens, Jeremy P.W. Heaton, et al.. (2003). Hypoxia Induced Resistance to Doxorubicin in Prostate Cancer Cells is Inhibited by Low Concentrations of Glyceryl Trinitrate. The Journal of Urology. 170(3). 1003–1007. 83 indexed citations

10.

Adams, Michael A., et al.. (2001). Nitric Oxide-Mediated Regulation of Chemosensitivity in Cancer Cells. JNCI Journal of the National Cancer Institute. 93(24). 1879–1885. 127 indexed citations

11.

Maxwell, Lori, et al.. (1999). Mechanical manipulation of bone and cartilage cells with ‘optical tweezers’. FEBS Letters. 459(1). 39–42. 36 indexed citations

12.

Elliott, B E, et al.. (1991). Capacity of CD8⁺ T Cells to Reject Immunogenic Variants of a Spontaneous Murine Carcinoma: Lack of Non‐Specific (NK1.1⁺) Effector Mechanisms. Scandinavian Journal of Immunology. 33(6). 683–690. 4 indexed citations

13.

Elliott, B E, et al.. (1988). Expression of epithelial-like markers and class I major histocompatibility antigens by a murine carcinoma growing in the mammary gland and in metastases: orthotopic site effects.. PubMed. 48(24 Pt 1). 7237–45. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact